As the federal government moves to reclassify cannabis and put it in a slightly less restrictive category, the plot thickens. On Monday, Smart Approaches to Marijuana (SAM) co-founder Kevin Abraham Sabet Sharghi, Ph.D., aka Kevin Sabet, posted on X allegations that claim the U.S. Drug Enforcement Administration (DEA) head Anne Milgram “did not sign” the order to reschedule cannabis under Schedule III.
BIG: I can now say with full confidence that the Administrator of DEA, Anne Milgram, did NOT sign the rescheduling order, breaking with five decades of precedent and established law and regulations (two confidential sources inside DEA and another outside DEA with intimate…— Kevin Sabet (@KevinSabet) May 6, 2024
“I can now say with full confidence that the Administrator of DEA, Anne Milgram, did NOT sign the rescheduling order, breaking with five decades of precedent and established law and regulations (two confidential sources inside DEA and another outside DEA with intimate knowledge tell me).”
The Associated Press reported on April 30 that the DEA will be rescheduling cannabis, moving the plant from Schedule I to Schedule III, following a lengthy process. In October 2022, President Joe Biden directed the Department of Health and Human Services (HHS) to review cannabis’s classification under Schedule I, a category reserved for dangerous drugs with no medical value, and media reports indicated that the DEA agreed to the changes.
The Drug Report indicates that this is the latest development in a multi-year process that has ruffled feathers on both sides of the debate.
Milgram testified before Congress on Tuesday at a budget hearing, but initially declined to comment on the Schedule III announcement because it is inappropriate for her to respond to questions because the rulemaking process is ongoing. The topic of the budget hearing is the DEA’s funding request for Fiscal …
Read More
Author: Benjamin M. Adams / High Times
